Exenatide
AGREE
AstraZeneca · Phase 2/3 · Status n/r · Enrollment 28
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Exenatide
AstraZeneca · Phase 2/3 · Status n/r · Enrollment 28
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.